New York, December 22, 2023 – Gilead Sciences (Nasdaq: GILD) has purchased 15 million shares of immunotherapeutics company, HOOKIPA Pharma’s (Nasdaq: HOOK), common stock for approximately $21.25 million, at a price of $1.4167 per share. Under the agreement, HOOKIPA is responsible for advancing its HIV program through the completion of a Phase 1b clinical trial. The company’s shares rose 52.65% on Thursday … Continue reading “HOOKIPA Stock Jumps Following $21.25M Gilead Equity Investment”
Author: Sophia Vida
Sofia has been writing for major news outlets for over 15 years. In her spare time she enjoys hiking, walking her dogs, and going to concerts.
Breaking News
PRISM Analysis: PetVivo Holdings Achieves Distribution Milestone; Shares Soar 40%
New York, December 22, 2023 – PetVivo Holdings, Inc. (Nasdaq: PETV) has achieved a distribution milestone, reporting…
December 22, 2023
Breaking News
PRISM Analysis: Why Did CareCloud Shares Jump This Week?
New York, December 22, 2023 – Healthcare technology solutions provider, CareCloud, Inc. (Nasdaq: CCLD) has seen a jump…
December 22, 2023
Breaking News
Ring In The New Year with Traditions and Trades: Cultural Celebrations and Stock Plays for a Prosperous Start
New York, December 21, 2023 – In two weeks, 2023 will be history so consider…
December 21, 2023
Breaking News
Palatin Technologies Sells Vyleesi in $171M Transaction
New York, December 21, 2023 – Palatin Technologies, Inc. (NYSE American: PTN) has completed the sale of Vyleesi® to…
December 21, 2023
Breaking News
SinglePoint CEO Releases Shareholder Letter Overviewing 2023 and Successful Listing on Cboe BZX Exchange
Successfully Uplisted to Cboe BZX Exchange December 15, 2023 Year to Date Revenue Crossing $30…
December 21, 2023
Breaking News
Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial
New York, December 21, 2023 – Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has received FDA clearance to conduct…
December 21, 2023
Breaking News
Clubhouse Media Group, Inc. Announces Separation from Agency to Focus Resources on HoneyDrip.com
LOS ANGELES, December 21, 2023 – Clubhouse Media Group, Inc. (OTC: CMGR) (“CMGR”), a social…
December 21, 2023
Breaking News
PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120%
New York, December 20, 2023 – PRISM MarketView, a leading provider of unbiased market insight…
December 20, 2023
Breaking News
PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success
New York, December 20, 2023 – Clinical-stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) is celebrating a year of…
December 20, 2023
Breaking News
Spooz, Inc. (SPZI) Completes Primary Acquisitions and Change of Control
Spooz Acquired Key JP Energy Assets; Vests Control to John K. Park Clearwater, FL., December…
December 20, 2023
Breaking News
Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership
New York, December 20, 2023 – Shares in payment network company, Affirm Holdings (Nasdaq: AFRM), jumped more…
December 20, 2023
Breaking News
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
–Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 – Lipella…
December 20, 2023
Breaking News
SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split
Phoenix, AZ, December 19, 2023 – SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a diversified…
December 19, 2023